BESIVANCE
BAUSCH & LOMB INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of BESIVANCE in Canada?
A shortage of BESIVANCE 0.6% is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 13, 2026), but it has not started yet.
Why is BESIVANCE not available?
The reason the manufacturer reported: Delay in shipping of the drug.
When will BESIVANCE be available again?
The manufacturer's estimated resolution date is November 2, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-11-02
~15 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02336847
Strength
0.6%
Dosage Form
SUSPENSION
Route
OPHTHALMIC
Active Ingredient
BESIFLOXACIN
Tier
Unrated
Last Updated
2026-10-13
Reason for Shortage
Delay in shipping of the drug.
Other Products from BAUSCH & LOMB INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
0.2% · DIN 02320924
1.5% · DIN 02456532
DIN 02237775
0.5% · DIN 02321114
0.5% · DIN 02435853
0.5% · DIN 02421941
DIN 02321696
0.025% · DIN 02517698
100% · DIN 02551403
1% · DIN 02148358
1% · DIN 02148382
2% · DIN 02148390